Rotate injection sites: Common sites include the abdomen (at least two inches away from the belly button), the top of the thighs, or the back of the upper arms
AOD9604 was specifically designed to include amino acid residues 177191 of hGH with an additional tyrosine residue at the N-terminus
These protocols are based on experimental and anecdotal use, not standardized medical guidelines For further questions email: [email protected] Send page to friend via: Share via:
Uses & Indication Overweight or obesity (BMI above 25) Visceral and abdominal fat reduction Metabolic slowdown associated with aging Enhancing fat loss while maintaining muscle mass Suitable for patients who cannot tolerate stimulant-based weight loss medications Can be used alongside GLP-1 medications but does not replace them Benefits Increases fat breakdown through lipolysis activation Reduces new fat formation Targets stubborn adipose tissue Does not affect blood sugar or IGF-1 levels Safe metabolic profile suitable for long-term use Supports gradual and steady fat loss Dosage & Injection Protocol Standard Dosing 500 mcg subcutaneously once daily Administer in the morning while fasting or before bed Avoid injecting within 2 hours of meals, especially carbohydrate-heavy meals Injection Timing Rules Inject on an empty stomach (avoid food for 2 hours before and 30 to 45 minutes after)
These materials are not intended for human or veterinary use, diagnostic procedures, or clinical applications.
Minor measuring errors shift concentration enough to create bad records, inconsistent draws, or unnecessary repeat work
